Marvell Technology (NASDAQ: MRVL) Raised by Oppenheimer and Citi

Marvell Technology received back-to-back analyst upgrades on Monday, May 26, 2026, with both Oppenheimer and Citi raising their price targets on the semiconductor maker. The moves reflect growing bullish sentiment around Marvell's positioning in the AI and data centre chip market, though neither firm disclosed specific new target figures in the available reports.

The stock climbed 2.96% to $196.33 on Monday following the upgrades, extending gains as investors digest the analysts' revised outlooks. The timing coincides with a broad rally in semiconductor stocks driven by expectations of sustained AI infrastructure spending.

By the Numbers

• Stock price: $196.33 (up 2.96% on Monday, May 26)
• Previous close: $190.69
• Forward P/E ratio: 35.99 (TTM — may not reflect latest quarter)
• Trailing P/E ratio: 64.16 (TTM — may not reflect latest quarter)
• Market cap: $171.9 billion

Why It Matters

Multiple analyst reassessments in quick succession often signal a shift in institutional conviction around a company's near-term trajectory or competitive positioning. For Marvell, the upgrades arrive as the semiconductor industry navigates elevated demand for AI-optimized chips and data centre processors. Oppenheimer and Citi's moves suggest both firms see the company gaining traction in markets where competition remains intense.

The lack of disclosed target figures in the headlines limits visibility into how much upside each bank expects, but the coordinated action indicates alignment on the company's medium-term earnings potential.

Wall Street View

While Oppenheimer and Citi's specific price targets were not published in the available coverage, the dual upgrades suggest a constructive consensus forming around Marvell's growth catalyst. Separately, BofA analyst Vivek Arya recently noted that Nvidia could reach $350 on the back of an "unprecedented" agentic AI chip cycle—commentary that implicitly reflects bullish sector sentiment that may benefit Marvell as well.

Investor Takeaway

Marvell's stock has recovered from broader chip sector weakness, and analyst upgrades from major houses add near-term momentum. Investors should monitor for the publication of the specific price targets to assess the magnitude of expected appreciation. With the company's forward P/E at 35.99x (TTM basis), valuation remains elevated relative to historical levels, warranting caution until full Q1 or Q2 earnings guidance clarifies growth visibility.